Fluid Biomed

Fluid Biomed is at the forefront of medical innovation, developing a groundbreaking solution for the treatment of brain aneurysms. The company has designed the world's first hybrid polymer-metal flow-diverting stent, a revolutionary medical device aimed at curing this potentially deadly condition.

This innovative stent is uniquely constructed using a combination of dissolving polymer and metal, providing a scaffold that promotes better healing and improved visualization of blood vessels. The device is engineered to be highly flexible, allowing for easy navigation through the delicate blood vessels of the brain using standard techniques familiar to physicians.

The stent's design is particularly noteworthy for its ability to gradually integrate into the blood vessel wall after curing the aneurysm, leaving minimal long-term impact. This feature, coupled with the polymer's invisibility to x-rays and its eventual dissolution, significantly reduces interference with follow-up CT and MRI scans. As a result, patients are spared from undergoing invasive angiogram tests and do not require lifelong blood thinners.

Fluid Biomed's stent works by slowing down blood flow inside the weakened area of the blood vessel, allowing the aneurysm to thrombose over time. This process effectively protects patients from the risk of rupture and stroke while maintaining normal blood flow to other areas of the brain. Laboratory data suggests that the unique construction of this hybrid polymer-metal stent provides excellent flow-diversion properties, matching or exceeding the performance of existing metal flow-diverters in the market.

The company's commitment to patient safety, treatment efficacy, and physician ease-of-use is evident in their approach to product development. With a team comprising academic specialists and practicing neurosurgeons, Fluid Biomed is well-positioned to optimize their medical device for real-world application, potentially revolutionizing the treatment of brain aneurysms and significantly improving patient outcomes.